General MedicationsINJECTIONGeneric
PRALIDOXIME CHLORIDE
PRALIDOXIME CHLORIDE
Standard Dose
300MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PRALIDOXIME CHLORIDE is listed in Drugs@FDA under application 018799 (NDA).
Marketing status: Discontinued Active ingredient PRALIDOXIME CHLORIDE Form and strength INJECTABLE;INJECTION - 300MG/ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 1983-04-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview PRALIDOXIME CHLORIDE is listed in Drugs@FDA under application 018799 (NDA). Marketing status: Discontinued Active ingredient PRALIDOXIME CHLORIDE Form and strength INJECTABLE;INJECTION - 300MG/ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 1983-04-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.